|
MTP
|
Midatech Pharma PLC
|
US
|
NASDAQ
|
|
MTPH
|
Midatech Pharma Plc
|
UK
|
LSE
|
|
MVF
|
Monash IVF Group Ltd
|
AU
|
ASX
|
|
MWG0
|
INMED PHARMACEUTICALS INC
|
DE
|
F
|
|
MYGN
|
Myriad Genetics, Inc.
|
US
|
NASDAQ
|
|
MYMX
|
Mymetics Corp
|
US
|
OTC
|
|
MYOV
|
Myovant Sciences Ltd.
|
US
|
NYSE
|
|
MYRX
|
Myrexis Inc
|
US
|
OTC
|
|
N1VO34
|
Novo Nordisk A/S
|
BR
|
SA
|
|
NAMSW
|
NewAmsterdam Pharma Company N.V. Warrant
|
US
|
US
|
|
NAVB
|
Navidea Biopharmaceuticals, Inc.
|
US
|
AMEX
|
|
NBIX
|
Neurocrine Biosciences, Inc.
|
US
|
NASDAQ
|
|
NBSE
|
NeuBase Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NC6
|
Nanollose Ltd
|
AU
|
ASX
|
|
NCNA
|
NuCana plc
|
US
|
NASDAQ
|
|
NERV
|
Minerva Neurosciences, Inc
|
US
|
NASDAQ
|
|
NGRC
|
National Graphite Corp
|
US
|
OTC
|
|
NLSPW
|
NLS Pharmaceutics AG
|
US
|
US
|
|
NLTX
|
Neoleukin Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NNBP
|
Nanobac Pharmaceuticals Incorporated
|
US
|
US
|